COVID-19: immunopathogenesis and Immunotherapeutics
First Affiliated Hospital of Zhengzhou University · University of Electronic Science and Technology of China · +4 more institutions
Abstract
The recent novel coronavirus disease (COVID-19) outbreak, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected patients worldwide. The host immune response to SARS-CoV-2 appears to play a critical role in disease pathogenesis and clinical manifestations. SARS-CoV-2 not only activates antiviral immune responses, but can also cause uncontrolled inflammatory responses characterized by marked pro-inflammatory cytokine release in patients with severe COVID-19, leading to lymphopenia, lymphocyte dysfunction, and granulocyte and monocyte abnormalities. These SARS-CoV-2-induced immune abnormalities may lead to infections by microorganisms, septic shock, and…
Citation impact
- FWCI
- 18.43
- Percentile
- 100%
- References
- 84
Authors
8- YLYang LiCorresponding
First Affiliated Hospital of Zhengzhou University
- SLShasha Liu
First Affiliated Hospital of Zhengzhou University
- JLJinyan Liu
First Affiliated Hospital of Zhengzhou University
- ZZZhixin Zhang
University of Electronic Science and Technology of China
- XWXiaochun Wan
Chinese Academy of Sciences, Shenzhen Institutes of Advanced Technology
Topics & keywords
- Immunology
- Immune system
- Medicine
- Cytokine storm
- Disease
- Immunopathology
- Pathogenesis
- Inflammation
- Good health and well-being